Neovasculgen: gene therapy of lower limb ischemia
Neovasculgen is based on a gene that produces a substance in the patient's cells that stimulates the growth of new blood vessels. For many patients with lower limb ischemia, the drug can become a real alternative to amputation.
02.04.2010